Susquehanna International Group, LLP Galectin Therapeutics Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.04 - $2.86 $1.38 Million - $1.93 Million	-676,400 Reduced 69.87%	291,700 $802,000
Q2 2024 Aug 15, 2024	BUY	$2.13 - $4.2 $1.97 Million - $3.89 Million	925,500 Added 2172.54%	968,100 $2.19 Million
Q1 2024 May 07, 2024	BUY	$1.6 - $2.44 $45,120 - $68,808	28,200 Added 195.83%	42,600 $101,000
Q4 2023 Feb 14, 2024	SELL	$1.6 - $2.18 $1,120 - $1,526	-700 Reduced 4.64%	14,400 $23,000
Q3 2023 Nov 14, 2023	SELL	$1.38 - $1.97 $31,739 - $45,310	-23,000 Reduced 60.37%	15,100 $28,000
Q2 2023 Aug 11, 2023	SELL	$1.32 - $2.08 $19,404 - $30,576	-14,700 Reduced 27.84%	38,100 $54,000
Q1 2023 May 16, 2023	SELL	$1.1 - $2.4 $16,390 - $35,760	-14,900 Reduced 22.01%	52,800 $110,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $1.66 $93,833 - $151,226	-91,100 Reduced 57.37%	67,700 $76,000
Q3 2022 Nov 14, 2022	BUY	$1.31 - $2.48 $64,452 - $122,016	49,200 Added 44.89%	158,800 $259,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.74 $92,225 - $134,850	-77,500 Reduced 41.42%	109,600 $144,000
Q1 2022 May 16, 2022	BUY	$1.61 - $2.31 $68,103 - $97,713	42,300 Added 29.21%	187,100 $301,000
Q4 2021 Feb 14, 2022	SELL	$2.07 - $3.8 $308,844 - $566,960	-149,200 Reduced 50.75%	144,800 $300,000
Q3 2021 Nov 15, 2021	BUY	$2.59 - $4.15 $529,914 - $849,090	204,600 Added 228.86%	294,000 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$2.07 - $5.1 $158,769 - $391,170	76,700 Added 603.94%	89,400 $286,000
Q1 2021 May 17, 2021	SELL	$1.96 - $2.57 $84,672 - $111,024	-43,200 Reduced 77.28%	12,700 $28,000
Q4 2020 Feb 16, 2021	SELL	$2.24 - $2.87 $84,672 - $108,486	-37,800 Reduced 40.34%	55,900 $125,000
Q3 2020 Nov 16, 2020	BUY	$2.53 - $3.64 $127,005 - $182,728	50,200 Added 115.4%	93,700 $250,000
Q2 2020 Aug 14, 2020	BUY	$1.66 - $3.15 $996 - $1,890	600 Added 1.4%	43,500 $133,000
Q1 2020 May 15, 2020	BUY	$1.51 - $3.0 $1,661 - $3,300	1,100 Added 2.63%	42,900 $84,000
Q4 2019 Feb 14, 2020	SELL	$2.79 - $4.32 $27,342 - $42,336	-9,800 Reduced 18.99%	41,800 $120,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.05 $198,900 - $268,515	-66,300 Reduced 56.23%	51,600 $189,000
Q2 2019 Aug 14, 2019	SELL	$3.61 - $5.0 $179,056 - $248,000	-49,600 Reduced 29.61%	117,900 $489,000
Q1 2019 May 15, 2019	SELL	$3.86 - $6.02 $164,822 - $257,053	-42,700 Reduced 20.31%	167,500 $856,000
Q4 2018 Feb 14, 2019	BUY	$3.43 - $5.74 $41,503 - $69,454	12,100 Added 6.11%	210,200 $721,000
Q3 2018 Nov 14, 2018	BUY	$3.68 - $6.93 $519,984 - $979,209	141,300 Added 248.77%	198,100 $1.19 Million
Q2 2018 Aug 14, 2018	BUY	$3.16 - $9.16 $2,528 - $7,328	800 Added 1.43%	56,800 $361,000
Q1 2018 May 15, 2018	SELL	$3.78 - $5.97 $7,938 - $12,537	-2,100 Reduced 3.61%	56,000 $265,000
Q4 2017 Feb 14, 2018	BUY	$1.54 - $3.34 $61,138 - $132,598	39,700 Added 215.76%	58,100 $194,000
Q3 2017 Nov 14, 2017	BUY	$1.67 - $2.3 $30,728 - $42,320	18,400	18,400 $39,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.65M

Call Options Held

1.16M

Put Options Held

1.98M

Vanguard Group Inc Valley Forge, PA

2.13M
Shares

$2.22 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.56M
Shares

$1.63 Million
0.0% of portfolio
Advisor Group Holdings, Inc. Phoenix, AZ

1.18M
Shares

$1.23 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

863K
Shares

$897,043
0.0% of portfolio
Commonwealth Equity Services, LLC

483K
Shares

$502,594
0.0% of portfolio

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $61.8M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account